ELAN CORP.
Healthcare · EUR · F
Price
€3.576
Cap
€216.53M
Earnings
—
30d Trend
-4.5%
35% annualised over 90 days
BRAIN47 SIGNAL
Raw weighted: 61×Macro 0.99 (−1%)=60
RISK
QUALITY
MOMENTUM
TECHNICAL
FUNDAMENTALS
Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%
BRAIN47 HORIZON ANALYSIS
12-24 month value thesis — fundamentally underpriced
BRAIN47'S ASSESSMENT
I rate ELAN CORP. at 60/100 — a STRONG reading on the Brain47 Signal. The strongest factor is fundamentals at 90/100. I classify this as a growth position with the strongest thesis on a long-term horizon.
PAST PERFORMANCE
1 MONTH
-3.8%
3 MONTHS
-9.3%
12 MONTHS
-17.9%
Trailing returns — past performance, not a projection.
DETAILED ANALYSIS
12-24 month value thesis — fundamentally underpriced. Fundamentals (90) and Quality (67) are the primary strengths. I note that momentum is the weakest area at 40/100 — this warrants monitoring. Historical volatility is moderate at 35%. I classify this as a growth position — positive trend direction combined with solid fundamentals points to capital appreciation.
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.